The association of ESBL with mortality in patients with bacteremia at the emergency department.

BACKGROUND

: is a common bloodstream infection pathogen in the emergency department (ED). Patients with extended-spectrum beta-lactamase (ESBL) have a higher risk of morbidity. However, there is still debate surrounding ESBL -associated mortality in community, intensive care unit, and tertiary care settings. In addition, there have been few studies regarding mortality in ESBL in ED settings, and results have been contradictory.

METHODS

: This was a retrospective cohort study conducted at the Department of Emergency Medicine, Faculty of Medicine, Khon Kaen University in Thailand aimed at evaluating the possible association between ESBL bacteremia and mortality in the ED. The inclusion criteria were age 18 years or over, clinical presentation suspicious of infection, and positive blood culture for . Predictors for mortality were analyzed by logistic regression analysis.

RESULTS

: During the study period, 273 patients presented at the ED with hemoculture positive for . Of those, 27 (9.89%) died. Five factors remained in the final model, of which plasma glucose levels, serum lactate levels, and ESBL were significantly associated with 28-day mortality in the ED with adjusted odds ratios of 0.970, 1.258, and 12.885, respectively. Plasma glucose of less than 113 mg/dL yielded a sensitivity of 80.95% and specificity of 64.29%, while serum lactate over 2.4 mmol/L had a sensitivity of 81.48% and specificity of 45.50%.

CONCLUSION

: ESBL , plasma glucose, and serum lactate levels were associated with 28-day mortality in patients with bacteremia presenting at the ED.